经导管主动脉瓣置换术后感染性心内膜炎的长期风险
该全国性观察性队列研究纳入2008至2016年丹麦无感染性心内膜炎病史且出院存活的TAVR患者2632例和孤立SAVR患者3777例,平均随访3.6年。TAVR组5年IE累积风险为5.8%,SAVR组为5.1%,多变量Cox分析显示TAVR与SAVR的IE风险无统计学显著差异(HR 1.12,95%CI 0.84-1.49)。
要点
- TAVR术后5年感染性心内膜炎累积风险为5.8%。
- TAVR与SAVR术后长期IE风险无显著差异(HR 1.12,95%CI 0.84-1.49)。
- TAVR组IE发生中位时间352天,短于SAVR组的625天。
核心结论
- TAVR术后5年IE发生率为5.8%,与SAVR术后发生率无显著差异。
研究设计与样本
- 全国性观察性队列研究,利用丹麦全国注册数据,纳入2008年1月1日至2016年12月31日期间接受TAVR或孤立SAVR、无IE病史且出院存活的患者。
- 共纳入TAVR患者2632例和孤立SAVR患者3777例,平均随访3.6年。
主要发现
- 随访期间TAVR组115例(4.4%)和SAVR组186例(4.9%)因IE入院。
- TAVR组IE粗发生率为1.6/100人年(95%CI 1.4-1.9),SAVR组为1.2/100人年(95%CI 1.0-1.4)。
- TAVR组1年IE累积风险为2.3%(95%CI 1.8%-2.9%),SAVR组为1.8%(95%CI 1.4%-2.3%)。
- TAVR组5年IE累积风险为5.8%(95%CI 4.7%-7.0%),SAVR组为5.1%(95%CI 4.4%-6.0%)。
- 多变量Cox分析显示TAVR与SAVR的IE风险无统计学显著差异(HR 1.12,95%CI 0.84-1.49)。
临床怎么用
- TAVR术后患者应关注长期IE风险,尤其术后早期(中位352天)出现感染症状时需警惕IE。
- TAVR与SAVR术后IE风险相当,临床随访策略可参照SAVR术后IE预防和监测原则。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients undergoing surgical aortic valve replacement (SAVR) are considered at high risk of infective endocarditis (IE). However, data on the risk of IE following transcatheter aortic valve replacement (TAVR) are sparse and limited by the lack of long-term follow-up as well as a direct comparison with patients undergoing SAVR. OBJECTIVES: This study sought to investigate the long-term incidence of IE in patients undergoing TAVR and to compare the long-term risk of IE with patients undergoing isolated SAVR. METHODS: In this nationwide observational cohort study, all patients undergoing TAVR and isolated SAVR from January 1, 2008, to December 31, 2016, with no history of IE and alive at discharge were identified using data from Danish nationwide registries. RESULTS: A total of 2,632 patients undergoing TAVR and 3,777 patients undergoing isolated SAVR were identified. During a mean follow-up of 3.6 years, 115 patients (4.4%) with TAVR and 186 patients (4.9%) with SAVR were admitted with IE. The median time from procedure to IE hospitalization was 352 days (25th to 75th percentile: 133 to 778 days) in the TAVR group and 625 days (25th to 75th percentile: 209 to 1,385 days) in the SAVR group. The crude incidence rates of IE were 1.6 (95% confidence interval [CI]: 1.4 to 1.9) and 1.2 (95% CI: 1.0 to 1.4) events per 100 person-years in TAVR and SAVR patients, respectively. The cumulative 1-year risk of IE was 2.3% (95% CI: 1.8% to 2.9%) and 1.8% (95% CI: 1.4% to 2.3%) in TAVR and SAVR patients, respectively. Correspondingly, the cumulative 5-year risk of IE was 5.8% (95% CI: 4.7% to 7.0%) and 5.1% (95% CI: 4.4% to 6.0%), respectively. In multivariable Cox proportional hazard analysis, TAVR was not associated with a statistically significant different risk of IE compared with SAVR (hazard ratio: 1.12; 95% CI: 0.84 to 1.49). CONCLUSIONS: The 5-year incidence of IE following TAVR was 5.8% and not significantly different than the incidence following SAVR.
引用
- Butt JH, Ihlemann N, De Backer O, et al. Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2019. PMID: 30947917. doi:10.1016/j.jacc.2018.12.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。